These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17542757

  • 1. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK.
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [Abstract] [Full Text] [Related]

  • 2. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 3. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW, Powell RJ, Lewis GK, Hone DM.
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [Abstract] [Full Text] [Related]

  • 4. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC.
    Vaccine; 2006 May 01; 24(18):3821-31. PubMed ID: 16098637
    [Abstract] [Full Text] [Related]

  • 5. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H, Dietrich G, Kaufmann SH.
    Biol Chem; 2001 Apr 01; 382(4):521-32. PubMed ID: 11405217
    [Abstract] [Full Text] [Related]

  • 6. Recombinant Salmonella vectors in vaccine development.
    Curtiss R, Kelly SM, Tinge SA, Tacket CO, Levine MM, Srinivasan J, Koopman M.
    Dev Biol Stand; 1994 Apr 01; 82():23-33. PubMed ID: 7958478
    [Abstract] [Full Text] [Related]

  • 7. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A, Klimuszko D.
    Pol J Vet Sci; 2009 Apr 01; 12(1):133-9. PubMed ID: 19459451
    [Abstract] [Full Text] [Related]

  • 8. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D, Weidinger G, Spreng S.
    Expert Rev Vaccines; 2007 Feb 01; 6(1):97-110. PubMed ID: 17280482
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL, Tinge SA, Killeen KP, Kochi SK.
    Curr Opin Mol Ther; 2005 Feb 01; 7(1):62-72. PubMed ID: 15732531
    [Abstract] [Full Text] [Related]

  • 10. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF, Dietrich G, Favre D.
    Vaccine; 2004 Jun 23; 22(19):2457-69. PubMed ID: 15193410
    [Abstract] [Full Text] [Related]

  • 11. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S, Viret JF.
    Vaccine; 2005 Mar 18; 23(17-18):2060-5. PubMed ID: 15755571
    [Abstract] [Full Text] [Related]

  • 12. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits.
    Ashby D, Leduc I, Lauzon W, Lee BC, Singhal N, Cameron DW.
    J Immunol Methods; 2005 Apr 18; 299(1-2):153-64. PubMed ID: 15914198
    [Abstract] [Full Text] [Related]

  • 13. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R, Simanski SP, Pathangey L, Stone AE, Brown TA.
    Vaccine; 2007 Jan 02; 25(1):117-26. PubMed ID: 16942819
    [Abstract] [Full Text] [Related]

  • 14. Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium.
    Gahan ME, Webster DE, Wesselingh SL, Strugnell RA.
    Vaccine; 2007 Feb 09; 25(8):1476-83. PubMed ID: 17126961
    [Abstract] [Full Text] [Related]

  • 15. The history of live bacterial vaccines.
    Lindberg AA.
    Dev Biol Stand; 1995 Feb 09; 84():211-9. PubMed ID: 7796956
    [Abstract] [Full Text] [Related]

  • 16. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
    Levine MM, Galen J, Barry E, Noriega F, Chatfield S, Sztein M, Dougan G, Tacket C.
    J Biotechnol; 1996 Jan 26; 44(1-3):193-6. PubMed ID: 8717403
    [Abstract] [Full Text] [Related]

  • 17. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
    Ning JF, Zhu W, Xu JP, Zheng CY, Meng XL.
    Vaccine; 2009 Feb 11; 27(7):1127-35. PubMed ID: 19071178
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A new concept to stimulate mucosal as well as systemic immunity by parenteral vaccination as applied to the development of a live attenuated Salmonella enterica serovar Dublin vaccine.
    Mizuno T, Ploeg R, Trott D.
    Vet Res; 2007 Feb 11; 38(6):773-94. PubMed ID: 17727804
    [Abstract] [Full Text] [Related]

  • 20. Live bacterial delivery systems for development of mucosal vaccines.
    Thole JE, van Dalen PJ, Havenith CE, Pouwels PH, Seegers JF, Tielen FD, van der Zee MD, Zegers ND, Shaw M.
    Curr Opin Mol Ther; 2000 Feb 11; 2(1):94-9. PubMed ID: 11249657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.